Dynavax Technologies
DVAX
$11.99
Share price
1.44%
Change (1 day)
4.44%
Change (1 year)
Categories
Dynavax Technologies (DVAX) - Total debt
Total debt on the balance sheet as of March 2024 : $0.25 B
According to Dynavax Technologies 's latest financial reports the company's total debt is $0.25 B. A company’s total debt is the sum of all current and non-current debts.
Dynavax Technologies - Total debt on balance sheet (from 2009 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.25 B | -0.42% |
| 2022-12-31 | $0.25 B | 0.24% |
| 2021-12-31 | $0.25 B | 18.15% |
| 2020-12-31 | $0.21 B | 0.65% |
| 2019-12-31 | $0.21 B | 114.58% |
| 2018-12-31 | $0.10 B | |
| 2014-12-31 | $9.55 M | |
| 2012-12-31 | $N/A | -100% |
| 2011-12-31 | $12.81 M | 8.73% |
| 2010-12-31 | $11.78 M | -4.85% |
| 2009-12-31 | $12.38 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $68.70 B | 27,214.61% | 🇺🇸 USA |
 Amgen AMGN | $64.02 B | 25,350.92% | 🇺🇸 USA |
 Biogen BIIB | $6.94 B | 2,661.60% | 🇺🇸 USA |
 Gilead Sciences GILD | $25.19 B | 9,915.78% | 🇺🇸 USA |
 Merck MRK | $34.21 B | 13,503.64% | 🇺🇸 USA |
 AstraZeneca AZN | $34.55 B | 13,635.62% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $22.45 B | 8,828.49% | 🇬🇧 UK |
 Agenus
AGEN | $88.88 M | -64.67% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $19.93 B | 7,826.28% | 🇮🇱 Israel |